摘要
目的探讨血清细胞间粘附分子(CAMs)在急性冠状动脉综合征(ACS)发生发展过程中的作用。方法用双抗体酶联免疫吸附法测定40例ACS患者及40例健康体检者血清可溶性细胞间粘附分子-1(sICAM-1)、血管细胞粘附分子-1(sVCAM-1)、E-选择素(sE-S)的浓度。结果ACS组血清sICAM-1、sVCAM-1及sE-S的浓度分别为(371.78±66.78)μg/L、(644.91±169.73)μg/L及(46.14±10.14)μg/L,明显高于正常对照组的(236.45±47.55)μg/L、(342.16±84.16)μg/L及(31.30±5.40)μg/L(P<0.05或P<0.01)。结论CAMs参与了ACS的发病过程。
Objective To discover the role of serum soluble cell adhesion molecules ( CAMs ) in the pathogenesis of the acute coronary syndrome (ACS ). Methods Serum soluble intercellular adhesion molecule-1(sICAM-1 ) ,soluble vascular cell adhesion molecule-1 ( sVCAM-1 ) and soluble E-selectin( sE-S) from 40 acute coronary syndrome patients and 40 healthy people were measured by ELISA. Results The concentration of serum sICAM-1 ( 371.78 ± 66.78 ) μg/L,sVCAM-1 ( 644.91 ± 169.73 ) μg/L and sE-S ( 46.14 ± 10. 14 ) μg/L were significandy higher than that of control group [ ( 236.45 ± 47.55 ) μg/L, ( 342. 16 ± 84. 16 )μg/L and ( 31.30 ± 5.40 )μg/L ( P 〈 0.05 or P 〈 0.01 ) ]. Conclusion CAMs might play an important role in the pathogenesis of acute coronary syndrome.
出处
《中国医药》
2006年第5期261-263,共3页
China Medicine
关键词
急性冠状动脉综合征
细胞间粘附分子-1
血管细胞粘附分子-1
Acute coronary syndrome
Soluble intercellular adhesion molecule-1
Soluble vascular cell adhesion molecule-1